BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2012
View Archived Issues
Parkinson's Disease Foundation awards grants to support research
Read More
First-in-human results show safety and immunogenicity of a novel AIDS vaccine
Read More
Researchers present results from taliglucerase alfa trials
Read More
Japanese researchers present novel GPR119 receptor agonists
Read More
Bionomics discloses new agents for CNS disorders
Read More
Merck & Co. patents novel dipeptidyl peptidase inhibitors
Read More
IRM discloses new Trk inhibitors
Read More
Phase III trial begins for theragnostic drug in patients with progressive midgut carcinoid
Read More
Baxter and Onconova enter into European licensing agreement for rigosertib
Read More
Intellikine divulges novel inhibitors of PI3Kalpha
Read More
Dompe presents new TRPM8 antagonists with potent activity in neuropathic pain models
Read More
Researchers at CSIC and the Universitat de Barcelona disclose new GSK-3 beta inhibitors
Read More
Belgian and U.S. researchers synthesize novel agents for viral infections
Read More
Urinary CCL18 assessed as a biomarker for Gaucher's disease
Read More
Bionor Pharma presents phase II results for HIV vaccine
Read More
Grifols updates on Alzheimer's disease research strategies
Read More
EB66 cell-based human influenza vaccine advances to phase III
Read More
Pharmacokinetic study of topical ketoprofen set to begin
Read More
Gamida Cell completes enrollment in phase I/II NiCord study
Read More
Phase II study begins of Zevalin in lymphoma
Read More
Health Canada approves Byetta added on to insulin glargine
Read More
Xcovery begins phase I/II trial of its angiogenesis inhibitor in wet AMD
Read More
Medivir and Janssen to conduct phase IIa trial of interferon-free combination for chronic HCV
Read More
Intellect Neurosciences and MRC Technology complete humanization of therapeutic antibody
Read More
Aerpio Therapeutics begins dosing in phase Ib/IIa trial of AKB-9778
Read More
PolyMedix receives NCI grant to study brilacidin for oral mucositis
Read More
Licensing agreement set after TXA-127 feasibility study
Read More